Vincristine Sulfate Injection (1 box and 1 vial)
Vincristine Sulfate Injection (1 vial)
Vincristine Sulfate Injection (box of 1 vial)
Vincristine Sulfate Injection (1 box and 1 vial)
Vincristine Sulfate Injection (1 vial)
Vincristine Sulfate Injection (box of 1 vial)
*Packaging color may differ according to distribution region.

Vincristine Sulfate Injection

VintinCare™
Vincristine Sulfate Injection is an antileukemia medicine indicated for cancer chemotherapy. This anti-cancer drug is manufactured by AdvaCare Pharma in ISO/GMP-certified facilities with the strictest quality control and safety measures implemented.

Dosage

Packaging

What is Vincristine Sulfate?

Therapeutic Class:

Active Ingredients: Vincristine Sulfate

Vincristine Sulfate is an antileukemic drug used in cancer chemotherapy, typically used to treat acute lymphocytic leukemia. This drug is also for Hodgkin's and non-Hodgkin's lymphomas, rhabdomyosarcoma, neuroblastoma, breast cancer, small cell lung cancer, uterine cervix cancer, colorectal cancer, and Wilms' tumor.

Vincristine Sulfate Injection is a vinca alkaloid salt derived from a common flowering herb, the periwinkle plant. The active ingredient, Vincristine, is a mitotic inhibitor, which slows and stops cells from growth and division, which may kill the cancer cells. Originally Vincristine was known by the name leurocristine, and it has also been referred to as "LCR" and "VCR."

AdvaCare Pharma is a trusted global supplier of Vincristine Sulfate Injection. We offer a wide range of high-quality and cost-effective oncology medications that are available for distribution. Our factories are GMP-certified and are regularly inspected to ensure they continue to meet the high standards necessary to comply with WHO guidelines and standards.

Why choose us as your Vincristine manufacturer?

AdvaCare Pharma manufactures Vincristine Injection, one of 40+ oncology treatments, according to rigorous GMP protocols at our state-of-the-art production facility. We are committed to producing quality-assured, cost-effective cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. As an established Vincristine manufacturer, we supply pharmaceutical distributors, hospitals and government institutions with reliable cancer drugs.

Uses

What is Vincristine Sulfate used for?

It is used to treat certain types of leukemia, including acute lymphocytic leukemia. It is also used as a combination therapy to treat:

  • breast cancer
  • colorectal cancer
  • Hodgkin's disease
  • neuroblastoma
  • non-Hodgkin's malignant lymphoma
  • rhabdomyosarcoma
  • small cell cancer of the lung
  • uterine cervix cancer
  • Wilms' tumor

How should Vincristine Sulfate Injection be used?

This medication is manufactured as a powder and stored in a vial. The powder is to be prepared into a solution, and after reconstitution, it should be administered by injection into a vein.

As Vincristine Sulfate Injection is a cytotoxic drug, caution should be used when preparing and administering the solution.

What dose should be given?

The usual dose for adults is 2mg weekly.

The usual dose for children is 2mg weekly, for 3 to 8 weeks.

Extreme care should be taken in administering this drug, as neurotoxicity appears to be dosage related.

Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

Side Effects

As with all pharmaceuticals, some unwanted effects can occur from the use of Vincristine Sulfate Injection.

Common side effects include, but may not be limited to:

  • constipation
  • headache
  • joint pain
  • pain in testicles
  • pain in fingers
  • weakness

Seek medical attention if the following develop:

  • blood in the urine
  • fever
  • cough

For a comprehensive list of all possible effects, consult a doctor.

If any symptoms persist or worsen, or you notice any other symptoms, please call your doctor immediately.

Precautions

Do NOT use Vincristine Sulfate Injection if:

  • You are allergic to any compounds within the medicine.
  • You are suffering from Charcot-Marie Tooth syndrome.

Some drug interactions with Vincristine Sulfate can decrease digoxin and phenytoin plasma concentration. Consult with your doctor about any medications you are taking before your treatment with Vincristine Sulfate Injection.

The use of Vincristine Sulfate during pregnancy or breastfeeding can be harmful to the fetus or baby. Consult a doctor or healthcare professional before having injections with Vincristine Sulfate.

Driving or operating machinery is generally considered safe, as Vincristine Sulfate is not typically associated with dizziness or drowsiness, although individual reactions to the medication may vary.

*Regulatory compliance may vary according to production standard, import requirements and/or manufacturing origin.
Dolores Carrillo Profile
Medically reviewed by Dolores Carrillo, Pharm.D., MDB
October 14, 2024

You might be interested in...

Methotrexate Injection (1 box and 1 vial)
Methotrexate Injection
MetrexCare™
Letrozole Tablets (box of 100 tablets)
Letrozole Tablets
LetroCare™
Tamoxifen Tablets (box of 100 tablets)
Tamoxifen Tablets
TamoxCare™
Granisetron HCl Injection (1 box and 1 vial)
Granisetron HCl Injection
GraniCare™
Anastrozole Tablets (box of 100 tablets)
Anastrozole Tablets
AnastroCare™
Exemestane Tablets (box of 30 tablets)
Exemestane Tablets
ExemCare™
Ondansetron HCl Tablets (box of 100 tablets)
Ondansetron Tablets
OndaCare™
Hydroxyurea Capsules (box of 100 capsules)
Hydroxyurea Capsules
HydroxCare™

Why AdvaCare Pharma?

As an industry leader, we are aware of our responsibility to provide affordable and sustainable solutions to improve healthcare worldwide.

High Quality Affordable Products
Globally Recognized Brands
Wide Product Range
Regulatory Affairs Expertise
Flexible Production Lines
Marketing & Logistics Support